Cancer Research UK logo.
SearchDonate
  • Search

A study to help doctors predict who will respond well to paclitaxel chemotherapy for cancer of the ovary (OXO PCR 01)

Overview

Cancer types:

Ovarian cancer

Status:

Closed

Phase:

Phase 0

Details

This study is looking at cancer samples, blood samples and scans to see how and why women with certain types of ovarian cancer do or don’t respond to paclitaxel chemotherapy.

Recruitment start: 26 November 2012

Recruitment end: 28 February 2016

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Ahmed Ahmed

Supported by

Biomedical Research Council (BRC)

Experimental Cancer Medicine Centre (ECMC)

Medical Research Council (MRC)

National Institute for Health Research (NIHR)

Oncology Clinical Trials Office (OCTO)

University of Oxford

Last reviewed: 28 Feb 2016

CRUK internal database number: 9958

Help and support